The American consumer gets a treatment that didn't exist yesterday and whose IP will be free in ~15 years for their tax dollars. A pretty reasonable give and take on the face of it.

(Not that polices to reduce the cost to Americans, especially relative to foreign markets, ought to be unpopular)